Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

A propos de Lite Strategy

Fondé2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Communauté
Twitter
Website
Étiquettes
Publicly listed company
Crypto Stocks

Trend of Hot Index Change

Aucun enregistrement

Membres de l'équipe

Frederick W. Driscoll
Frederick W. Driscoll

Chairperson and Non-Executive Director

Justin (Jay) File
Justin (Jay) File

Chief Executive Officer and Chief Financial Officer

Détails du financement

Post-IPO(2025-07-21)
Montant€87,43M
Estimation--